Published in Cancer Weekly, March 6th, 2007
Adeza's key product, FullTerm(TM), The Fetal Fibronectin Test, is used by OBGYN's to identify women at risk of preterm birth. The tests are processed by hospital and reference...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.